Paul Logan: Decoding the Words ‘He’s on blood thinners’
Paul Logan, Founder of Advanced Practice Ready, shared a post on LinkedIn:
“‘He’s on blood thinners.’
What does that even mean?
- Anticoagulants?
- Antiplatelet agents?
- Both?
It’s imprecise.
And imprecise language in clinical settings leads to imprecise thinking. And sometimes ‘precisely’ the wrong outcome.
An anticoagulant (warfarin, apixaban, rivaroxaban, heparin) inhibits clotting factors in the coagulation cascade.
It prevents thrombus formation and propagation.
We use them for atrial fibrillation, DVT, PE, and mechanical valves, among others.
An antiplatelet agent (aspirin, clopidogrel, ticagrelor, prasugrel) inhibits platelet aggregation.
Different mechanism entirely.
We use them after PCI, in ACS, and for secondary prevention of atherosclerotic events.
And we keep going back and forth on their value for primary prevention.
- They are not interchangeable.
- They don’t do the same thing.
- They don’t protect against the same problems.
So let’s stop referring to them like they are the same.
A patient with a brand new drug-eluting stent who’s on apixaban for afib is not ‘covered’ for stent thrombosis.
The anticoagulant doesn’t replace the antiplatelet.
A patient on DAPT after a PCI is not ‘covered’ for their afib.
The antiplatelets don’t prevent cardioembolic stroke the way an anticoagulant does.
When you say ‘blood thinner,’ you’ve collapsed two entirely different pharmacologic strategies into one word.
And the patient hears it that way too. They think one pill handles everything.
Call the drug what it is.
Call the mechanism what it is. Your patient’s safety starts with your precision.
The APP Cardiology Academy launches May 1 with a full module on antithrombotic therapy for NPs and PAs.”
Stay updated with Hemostasis Today.
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC
-
Apr 30, 2026, 16:54Daniel Ben-Mordechay: Deep Vein Thrombosis and the Power of POCUS
-
Apr 30, 2026, 16:53Nicolas Hubacz: Natural Killer Cells versus Cancer
-
Apr 30, 2026, 16:52Augustina Isioma Ikusemoro: Malaria Doesn’t Only Come from Mosquitoes sometimes it Travels Through Blood
-
Apr 30, 2026, 16:51Join Our Next Gene Therapy Webinar – EAHAD
-
Apr 30, 2026, 16:51Krisstina Gowin: The Blood Tells a Story Long Before Diagnosis – Are We Listening Early Enough?
-
Apr 30, 2026, 16:49Shibani Pati: Freeze Dried Platelet Derived Biologic for TBI
-
Apr 30, 2026, 16:48Assessing the Efficacy and Safety of intravenous Tenecteplase for Acute CRAO – NEJM